NEWTOWN, Pa.--(BUSINESS WIRE)--May 3, 2006--CollaGenex Pharmaceuticals, Inc. (NASDAQ:CGPI - News) today reported financial results for the quarter ended March 31, 2006. Total revenues for the first quarter of 2006 were approximately $3.7 million compared to approximately $12.0 million in the first quarter of 2005, reflecting significantly reduced sales of Periostat® following the introduction of generic competition in May 2005.
